Regulon

Regulon: R-3229

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
171.7897410Pr-135Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
51360 ENSG00000012174 MBTPS2 O43462
25937 ENSG00000018408 WWTR1 Q9GZV5
9517 ENSG00000100596 SPTLC2 O15270
4790 ENSG00000109320 NFKB1 P19838
10124 ENSG00000122644 ARL4A P40617
9375 ENSG00000125304 TM9SF2 A0A024QYR8
3572 ENSG00000134352 IL6ST Q5FC07
351 ENSG00000142192 APP P05067
7357 ENSG00000148154 UGCG Q16739
26091 ENSG00000148634 HERC4 Q5GLZ8
84159 ENSG00000150347 ARID5B Q14865
7402 ENSG00000152818 UTRN P46939
476 ENSG00000163399 ATP1A1 P05023
10395 ENSG00000164741 DLC1 Q96QB1
6774 ENSG00000168610 STAT3 P40763
23333 ENSG00000173852 DPY19L1 Q2PZI1
7328 ENSG00000186591 UBE2H A4D1L5

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
PONEZUMABAPPAntibodyBINDING AGENTBeta amyloid A4 protein binding agent20
CRENEZUMABAPPAntibodyINHIBITORBeta amyloid A4 protein inhibitor30
DANVATIRSENSTAT3OligonucleotideANTISENSE INHIBITORSTAT-3 mRNA 3'UTR antisense inhibitor20
EDASALONEXENTNFKB2Small moleculeINHIBITORNuclear factor NF-kappa-B complex inhibitor30
LANATOSIDE CATP1A1Small moleculeINHIBITORSodium/potassium-transporting ATPase inhibitor40
ELIGLUSTATUGCGSmall moleculeINHIBITORCeramide glucosyltransferase inhibitor40
GANTENERUMABAPPAntibodyBINDING AGENTBeta amyloid A4 protein binding agent30
SOLANEZUMABAPPAntibodyBINDING AGENTBeta amyloid A4 protein binding agent30
ELIGLUSTAT TARTRATEUGCGSmall moleculeINHIBITORCeramide glucosyltransferase inhibitor40
MIGLUSTATUGCGSmall moleculeINHIBITORCeramide glucosyltransferase inhibitor40
DIGOXINATP1A1Small moleculeINHIBITORSodium/potassium-transporting ATPase inhibitor40
ACETYLDIGITOXINATP1A1Small moleculeINHIBITORSodium/potassium-transporting ATPase inhibitor40
BAPINEUZUMABAPPAntibodyBINDING AGENTBeta amyloid A4 protein binding agent30
GSK933776APPAntibodyBINDING AGENTBeta amyloid A4 protein binding agent20
SATRALIZUMABIL6RAntibodyANTAGONISTIL6Ralpha/GP130 antagonist40
LUCERASTATUGCGSmall moleculeINHIBITORCeramide glucosyltransferase inhibitor30
ADUCANUMABAPPAntibodyBINDING AGENTBeta amyloid A4 protein binding agent40
TRAMIPROSATEAPPSmall moleculeSTABILISERBeta amyloid A4 protein stabiliser30
DIGITOXINATP1A1Small moleculeINHIBITORSodium/potassium-transporting ATPase inhibitor40
LECANEMABAPPAntibodyINHIBITORBeta amyloid A4 protein inhibitor30
DONANEMABAPPAntibodyDISRUPTING AGENTBeta amyloid A4 protein disrupting agent30
VANUTIDE CRIDIFICARAPPProteinVACCINE ANTIGENBeta amyloid A4 protein vaccine antigen20
DESLANOSIDEATP1A1Small moleculeINHIBITORSodium/potassium-transporting ATPase inhibitor40
ISTAROXIMEATP1A1Small moleculeINHIBITORSodium/potassium-transporting ATPase inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-3229

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs